Ilex Capital Partners (Uk) LLP Merck & Co., Inc. Transaction History
Ilex Capital Partners (Uk) LLP
- $2.45 Trillion
- Q1 2025
A detailed history of Ilex Capital Partners (Uk) LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Ilex Capital Partners (Uk) LLP holds 28,372 shares of MRK stock, worth $2.2 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
28,372Holding current value
$2.2 Million% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,891Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.6 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.35 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.34 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.63 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $197B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...